Innominato, Pasquale F <br/><br/>
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).  [electronic resource] 

 -  Chronobiology international  Aug 2011 
 - 586-600 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-6073 
<br/><br/><label>Standard No.: </label>10.3109/07420528.2011.597532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biological Clocks--physiology<br/>Circadian Rhythm--physiology<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neutropenia--chemically induced<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Prognosis<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult